Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Non-small Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00071344
What this trial is testing

Analysis of Brain Metastasis in Patients With Lung Cancer

Who this might be right for
Carcinoma, Non-Small -Cell Lung
National Institute of Neurological Disorders and Stroke (NINDS) 78
Large-scale testing (Phase 3)Study completedNCT03215706
What this trial is testing

Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 719
Not applicableLooking for participantsNCT07325864
What this trial is testing

Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

Who this might be right for
NSCLCLung Cancer (Diagnosis)
European Institute of Oncology 25
Testing effectiveness (Phase 2)Study completedNCT00541099
What this trial is testing

Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 11
Testing effectiveness (Phase 2)Study completedNCT00309998
What this trial is testing

Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Rochester 50
Not applicableApproved For MarketingNCT04204928
What this trial is testing

Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTC

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid Cancer
Blueprint Medicines Corporation
Testing effectiveness (Phase 2)WithdrawnNCT06555263
What this trial is testing

Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung CancerLung Cancer MetastaticLung Cancer, Nonsmall Cell+3 more
Sutro Biopharma, Inc.
Not applicableStudy completedNCT00094822
What this trial is testing

Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
Amgen 90
Testing effectiveness (Phase 2)Looking for participantsNCT06010329
What this trial is testing

Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Teligene US 66
Testing effectiveness (Phase 2)Study completedNCT00227019
What this trial is testing

Phase 2 Trial of Bevacizumab in Combination With Pemetrexed

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Lung CancerNeoplasm Metastasis
Heather Wakelee 16
Testing effectiveness (Phase 2)Ended earlyNCT04984811
What this trial is testing

NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungNon-Small Cell Lung CancerNon-Small Cell Lung Carcinoma+2 more
NeoImmuneTech 33
Not applicableUnknownNCT05513664
What this trial is testing

Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung CancerEGFR Exon20 Insertion Mutations
Shanghai JMT-Bio Inc. 80
Testing effectiveness (Phase 2)UnknownNCT04148898
What this trial is testing

Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis

Who this might be right for
Leptomeningeal MetastasisNon-small Cell Lung CancerEGFR Activating Mutation
Second Affiliated Hospital of Nanchang University 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05246514
What this trial is testing

A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC

Who this might be right for
HER2-mutant Non-Small Cell Lung Cancer
AstraZeneca 72
Early research (Phase 1)WithdrawnNCT01562301
What this trial is testing

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Chemotherapeutic Agent ToxicityLung Cancer
M.D. Anderson Cancer Center
Post-approval studies (Phase 4)Active Not RecruitingNCT05689671
What this trial is testing

Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
Nikolaj Frost MD 136
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Early research (Phase 1)Active Not RecruitingNCT04007744
What this trial is testing

Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+19 more
Mayo Clinic 36
Large-scale testing (Phase 3)Active Not RecruitingNCT06140836
What this trial is testing

Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bristol-Myers Squibb 190
Testing effectiveness (Phase 2)UnknownNCT02897479
What this trial is testing

A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer

Who this might be right for
Lung Sarcomatoid Carcinoma
Hutchison Medipharma Limited 76
Next Page